These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16206109)

  • 1. Resistance testing in drug-naive HIV-infected patients: is it time?
    Hecht FM; Grant RM
    Clin Infect Dis; 2005 Nov; 41(9):1324-5. PubMed ID: 16206109
    [No Abstract]   [Full Text] [Related]  

  • 2. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.
    Sax PE; Islam R; Walensky RP; Losina E; Weinstein MC; Goldie SJ; Sadownik SN; Freedberg KA
    Clin Infect Dis; 2005 Nov; 41(9):1316-23. PubMed ID: 16206108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral resistance in clinical practice.
    Daar ES
    J Int Assoc Physicians AIDS Care (Chic); 2003 Sep; 2 Suppl 1():S4-18. PubMed ID: 14569655
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiretroviral drug resistance and resistance testing.
    Gallant JE
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
    van Zyl GU; Frenkel LM; Chung MH; Preiser W; Mellors JW; Nachega JB
    AIDS; 2014 Nov; 28(18):2643-8. PubMed ID: 25493592
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral drug resistance among treatment-naïve HIV-1-infected persons in Washington, D.C.
    Boyd AC; Herzberg EM; Marshall MM; Lamparello NA; De Leon MA; Porter A; Evans CH; Doshi S; Shahkolahi A; Dekker D; Relf MV
    AIDS Patient Care STDS; 2008 Jun; 22(6):445-8. PubMed ID: 18462072
    [No Abstract]   [Full Text] [Related]  

  • 8. Case 11-2009: a man with fever, headache, rash, and vomiting.
    Leiner S
    N Engl J Med; 2009 Jul; 361(3):313; author reply 313-4. PubMed ID: 19610167
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Waters et al. "Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia ...".
    Kan VL; Gale HB; Shinol RC
    AIDS; 2006 Oct; 20(15):1991-2. PubMed ID: 16988529
    [No Abstract]   [Full Text] [Related]  

  • 10. The evolving role of antiretroviral drug resistance testing in HIV-infected individuals.
    Idemyor V
    HIV Clin Trials; 2002; 3(5):413-7. PubMed ID: 12407491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline antiretroviral resistance and clinical outcomes in an urban HIV clinic.
    Klibanov OM; Dolder CR; Assefa F; Ekwonu TJ
    AIDS Patient Care STDS; 2013 Apr; 27(4):205-7. PubMed ID: 23514132
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV resistance testing. A clinical tool.
    Paul SM; Jorden VS
    N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study.
    Kim Y; Chin BS; Kim G; Shin HS
    J Korean Med Sci; 2018 Jun; 33(25):e173. PubMed ID: 29915524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects.
    Vicenti I; Razzolini F; Saladini F; Romano L; Zazzi M
    Clin Infect Dis; 2007 Jun; 44(12):1657-61. PubMed ID: 17516412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial commentary: monitoring early warning indicators for HIV drug resistance in South Africa: challenges and opportunities.
    Rossouw TM
    Clin Infect Dis; 2014 Jun; 58(11):1615-7. PubMed ID: 24585563
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to HIV drugs in UK may be lower in some areas.
    Fox JM; Fidler S; Weber J
    BMJ; 2006 Jan; 332(7534):179-80. PubMed ID: 16424507
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to antiviral drugs is climbing.
    Kmietowicz Z
    BMJ; 2005 Aug; 331(7512):308. PubMed ID: 16081434
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral treatment for HIV-infected infants exposed to nevirapine.
    Wagner TA; Frenkel LM
    JAMA; 2010 Dec; 304(23):2589; author reply 2589-90. PubMed ID: 21156944
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV Drug Resistance - An Emerging Threat to Epidemic Control.
    Beyrer C; Pozniak A
    N Engl J Med; 2017 Oct; 377(17):1605-1607. PubMed ID: 29069566
    [No Abstract]   [Full Text] [Related]  

  • 20. Is Genotype Testing Really Cost-Effective for Primary Resistance in Brazil?
    Ramos CG; Fisch P; Ferreira de Azeredo-Da-Silva AL
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):e54-6. PubMed ID: 26505332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.